Biographical Info

Dr. Furmanski’s background is in cancer molecular and cell biology, mechanisms of tumor progression, experimental therapeutics of cancer and other invasive/infectious processes, preclinical and human clinical trials. He has expertise in a number of areas, including pathogenesis of environmental toxin-induced disease, role of macrophages in inflammatory processes related to environmental exposures, health effects of nanoparticles, genetic and epigenetic regulation of cellular functions, among others. As a result of long service to the scientific community on a number of Editorial Boards, grant review committees, advisory boards, he is very active as a mentor for junior faculty and those newly moving into the field (as well as more senior members) in many aspects of the scientific and administrative process, including interactions with industry (big pharma, biotech, materials and devices).

Scholarly Activities

• Member and Inaugural Chair, Pathology C (Cancer Molecular Pathobiology/CAMP) Study Section, National Institutes of Health, June 2001 – October 2003
• Member, Advisory Committee for Oncologic Sciences, Center for Scientific Review, National Institutes of Health, January – June 1999 – June 2000
• Member, National Institutes of Health Reviewers Reserve, July 1993 – July 1998
• Member, Pathology B Study Section, Division of Research Grants, National Institutes of Health, October 1988 – June 1993
• Chairman, Cancer Biology and Immunology Contracts Review Committee, National Cancer                 Institute,   May 1985 – October 1987

Recent Publications

1. Abratenko, P, Alterkait, O, Andrade Aldana, D, Arellano, L, Asaadi, J, Ashkenazi, A, Balasubramanian, S, Baller, B, Barr, G, Barrow, D et al.. First Simultaneous Measurement of Differential Muon-Neutrino Charged-Current Cross Sections on Argon for Final States with and without Protons Using MicroBooNE Data. Phys Rev Lett. 2024;133 (4):041801. doi: 10.1103/PhysRevLett.133.041801. PubMed PMID:39121397
2. Abratenko, P, Alterkait, O, Andrade Aldana, D, Arellano, L, Asaadi, J, Ashkenazi, A, Balasubramanian, S, Baller, B, Barr, G, Barrow, D et al.. First Search for Dark-Trident Processes Using the MicroBooNE Detector. Phys Rev Lett. 2024;132 (24):241801. doi: 10.1103/PhysRevLett.132.241801. PubMed PMID:38949335
3. Abratenko, P, Alterkait, O, Andrade Aldana, D, Anthony, J, Arellano, L, Asaadi, J, Ashkenazi, A, Balasubramanian, S, Baller, B, Barr, G et al.. First Measurement of η Meson Production in Neutrino Interactions on Argon with MicroBooNE. Phys Rev Lett. 2024;132 (15):151801. doi: 10.1103/PhysRevLett.132.151801. PubMed PMID:38683006
4. Eddy, K, Gupta, K, Eddin, MN, Marinaro, C, Putta, S, Sauer, JM Jr, Chaly, A, Freeman, KB, Pelletier, JC, Fateeva, A et al.. Assessing Longitudinal Treatment Efficacies and Alterations in Molecular Markers Associated with Glutamatergic Signaling and Immune Checkpoint Inhibitors in a Spontaneous Melanoma Mouse Model. JID Innov. 2024;4 (2):100262. doi: 10.1016/j.xjidi.2024.100262. PubMed PMID:38445232 PubMed Central PMC10914525
5. Abratenko, P, Alterkait, O, Andrade Aldana, D, Arellano, L, Asaadi, J, Ashkenazi, A, Balasubramanian, S, Baller, B, Barr, G, Barrow, D et al.. Search for Heavy Neutral Leptons in Electron-Positron and Neutral-Pion Final States with the MicroBooNE Detector. Phys Rev Lett. 2024;132 (4):041801. doi: 10.1103/PhysRevLett.132.041801. PubMed PMID:38335355
6. Abratenko, P, Alterkait, O, Andrade Aldana, D, Anthony, J, Arellano, L, Asaadi, J, Ashkenazi, A, Balasubramanian, S, Baller, B, Barr, G et al.. First Double-Differential Measurement of Kinematic Imbalance in Neutrino Interactions with the MicroBooNE Detector. Phys Rev Lett. 2023;131 (10):101802. doi: 10.1103/PhysRevLett.131.101802. PubMed PMID:37739352
7. Kabeya, V, Puthussery, S, Furmanski, A. Barriers and facilitators to genetic testing for breast and ovarian cancer amongst Black African women in Luton (UK). J Genet Couns. 2024;33 (2):425-444. doi: 10.1002/jgc4.1742. PubMed PMID:37403830